Chemours CC Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $5.81B+0.4% | $5.78B-4.9% | $6.08B-10.5% | $6.79B+7.1% | ||
| $4.91B+5.7% | $4.64B-2.8% | $4.77B-7.8% | $5.18B+4.3% | ||
| $902M-21.1% | $1.14B-12.5% | $1.31B-19.2% | $1.62B+17.0% | ||
| 15.5%-4.2pp | 19.8%-1.7pp | 21.5%-2.3pp | 23.8%+2.0pp | ||
| $108M-0.9% | $109M+0.9% | $108M-7.7% | $117M+9.3% | ||
| $799M+33.6% | $598M-53.5% | $1.29B+81.3% | $710M+19.5% | ||
| $966M+17.4% | $823M-46.8% | $1.55B+83.4% | $844M+19.5% | ||
| $269M+1.9% | $264M+26.9% | $208M+28.4% | $162M-12.0% | ||
| $26M— | —— | —— | —— | ||
| -$277M-356% | $108M+134% | -$318M-143% | $741M+9.3% | ||
| —— | $37M+156% | -$66M-140% | $163M+136% | ||
| -$386M-644% | $71M+130% | -$237M-141% | $578M-5.1% | ||
| -6.6%-7.9pp | 1.2%+5.1pp | -3.9%-12.4pp | 8.5%-1.1pp | ||
| -$2.56-669% | $0.45+128% | -$1.60-145% | $3.56-1.7% | ||
| $332M-50.0% | $664M+234% | $199M-83.3% | $1.2B+1.5% | ||
| 5.7%-5.8pp | 11.5%+8.2pp | 3.3%-14.3pp | 17.6%-1.0pp | ||
| -$8M-102% | $372M+438% | -$110M-112% | $903M+4.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Chemours's revenue?
- Chemours (CC) generated $5.8B in revenue over the trailing twelve months, up 0.5% year over year.
- Is Chemours profitable?
- Chemours is not currently profitable: it reported a net loss of $410.0M over the trailing twelve months, a -7.0% net margin.
- What is Chemours's earnings per share?
- Chemours's diluted EPS over the trailing twelve months is $-2.72.
- Where does Chemours's income statement data come from?
- Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
